Interactions Of Different Sartans with the Bilayer Interface Studied by Saxs

M. RAPPOLT; B. SARTORI; A. HODZIC; G. PABST; T. MAVROMOUSTAKOS

doi:10.3797/scipharm.cespt.8.POT08

You are currently viewing a new version of our website. To view the old version click .

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).

Conference Report

12 July 2010

Interactions Of Different Sartans with the Bilayer Interface Studied by Saxs

and

Institute of Biophysics and Nanosystems Research, Austrian Academy of Sciences, 8042 Graz, Austria

Research Center Pharmaceutical Engineering GmbH, 8010 Graz, Austria

Chemistry Department, National and Kapodistrian University of Athens, Panepistimioupolis Zographou 15771, Greece

Author to whom correspondence should be addressed.

Sci. Pharm.2010, 78(3), 723;https://doi.org/10.3797/scipharm.cespt.8.POT08

Version Notes

Order Reprints

Abstract

This work presents a thorough investigation of the interaction of the novel synthetic pyrrolidinone analog MMK3 and other SARTANS (losartan, valsartan and candesartan) with the model membrane system of dipalmitoylphosphatidylcholine (DPPC). [...]

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Defining Carbohydrate Targets on Osteoarthritic Chondrocytes using RT-qPCR and LC-ESI-MS

Density Functional Theory Calculations on Methylated β-Cyclodextrins